about
The gut microbiota ellagic acid-derived metabolite urolithin A and its sulfate conjugate are substrates for the drug efflux transporter breast cancer resistance protein (ABCG2/BCRP).Role of ABC transporters in veterinary drug research and parasite resistance.Fluoroquinolone efflux mediated by ABC transporters.The ABC membrane transporter ABCG2 prevents access of FAAH inhibitor URB937 to the central nervous systemModulation of the activity of ABC transporters (P-glycoprotein, MRP2, BCRP) by flavonoids and drug response.Antioxidant profile of hyaluronan: physico-chemical features and its role in pathologies.Novel in vitro systems for prediction of veterinary drug residues in ovine milk and dairy products.Inhibition of ABCG2/BCRP transporter by soy isoflavones genistein and daidzein: effect on plasma and milk levels of danofloxacin in sheep.Analysis of the effect of the bovine adenosine triphosphate-binding cassette transporter G2 single nucleotide polymorphism Y581S on transcellular transport of veterinary drugs using new cell culture models.Differential inhibition of murine Bcrp1/Abcg2 and human BCRP/ABCG2 by the mycotoxin fumitremorgin C.In vivo inhibition of BCRP/ABCG2 mediated transport of nitrofurantoin by the isoflavones genistein and daidzein: a comparative study in Bcrp1 (-/-) mice.In vitro and in vivo interaction of moxidectin with BCRP/ABCG2.Involvement of breast cancer resistance protein (ABCG2) in the biliary excretion mechanism of fluoroquinolones.Reevaluation of the roles of ABCG2 in the disposition of genistein.Effects of triclabendazole on secretion of danofloxacin and moxidectin into the milk of sheep: role of triclabendazole metabolites as inhibitors of the ruminant ABCG2 transporter.Involvement of breast cancer resistance protein (BCRP1/ABCG2) in the bioavailability and tissue distribution of trans-resveratrol in knockout mice.Milk secretion of nitrofurantoin, as a specific BCRP/ABCG2 substrate, in assaf sheep: modulation by isoflavones.Effect of chronic ethanol ingestion and exercise training on skeletal muscle in rat.Protective effects of Panax ginseng on muscle injury and inflammation after eccentric exercise.Effects of netobimin treatment on the glucose and glycogen contents of Echinococcus granulosus cysts from gerbils.Mitochondrial, sarcoplasmic membrane integrity and protein degradation in heart and skeletal muscle in exercised rats.Effect of amphiphilic surfactant agents on the gastrointestinal absorption of albendazole in cattle.Intestinal elimination of albendazole sulfoxide: pharmacokinetic effects of inhibitors.Ginseng increases intestinal elimination of albendazole sulfoxide in the rat.Ginseng administration protects skeletal muscle from oxidative stress induced by acute exercise in rats.Natural allelic variants of bovine ATP-binding cassette transporter ABCG2: increased activity of the Ser581 variant and development of tools for the discovery of new ABCG2 inhibitors.Comparative study of hyaluronic derivatives: rheological behaviour, mechanical and chemical degradation.An altered tissue distribution of flaxseed lignans and their metabolites in Abcg2 knockout mice.Flaxseed-enriched diets change milk concentration of the antimicrobial danofloxacin in sheep.Inhibitory effects of different antioxidants on hyaluronan depolymerization.Role of ABCG2 in transport of the mammalian lignan enterolactone and its secretion into milk in Abcg2 knockout mice.Apoptosis and nitric oxide in an experimental model of osteoarthritis in rabbit after hyaluronic acid treatment.Improved LC method to determine ivermectin in plasma.Involvement of breast cancer resistance protein (BCRP/ABCG2) in the secretion of danofloxacin into milk: interaction with ivermectin.Effect of bovine ABCG2 Y581S polymorphism on concentrations in milk of enrofloxacin and its active metabolite ciprofloxacin.Effect of bovine ABCG2 polymorphism Y581S SNP on secretion into milk of enterolactone, riboflavin and uric acid.ABCG2/BCRP interaction with the sea grass Thalassia testudinum.Randomised controlled trial of efficacy of albendazole in intra-abdominal hydatid disease.Absorption and metabolism of albendazole after intestinal ischemia/reperfusion.Bioavailability of the Glucuronide and Sulfate Conjugates of Genistein and Daidzein in Breast Cancer Resistance Protein 1 Knockout Mice
P50
Q34668255-FDEE449F-5F82-4031-BF29-E987045CDBE2Q36446981-42C5F1A4-7181-43B4-9698-491E53CC829DQ37058802-DE933E8D-41BA-4398-8517-09BAC21105C3Q37059699-B6933B21-33E5-45D5-8293-F4A7574201C5Q37526729-BDF01B82-EA1C-4387-B7A7-55EC84EF950CQ37703267-506B1EEC-3F5D-4DC1-97B5-B1C05C4DDE28Q39010590-C78291F7-9CE7-4456-973A-4BBEBF945A72Q39256206-BCA90902-2307-4114-B601-D70492B79DF5Q39494005-50F97B23-4856-45D9-870E-1239F0404274Q39676550-501C5B1D-7360-4A73-A198-5DB08E68DB31Q39683616-819AB066-696A-4D32-9A91-3ABBCD017BC2Q39854242-4DF6F82B-0E46-4385-AB8C-B0EE8958000DQ40105359-911BCC88-B504-4946-ADCF-21B9B32136FAQ42411453-57641A35-FC7A-4C6A-80ED-141808D0652CQ42443739-97CA1CDA-0B5A-4E52-A144-E5CA534BA529Q43128084-F46CDAD8-2016-4C73-8E91-2443DE7D3A3BQ43276464-A14CE3C7-9BBE-4351-9D49-1FAFE6B64724Q43685930-5C9E1CCA-5EB4-44A7-8656-516FD2DEE7EFQ43794330-C012E746-4C1F-4A5D-AD64-079DA56BE34DQ43894303-C17F3BE5-C610-4B53-8E91-BE070E1D6158Q44324403-FFC73065-B62F-473D-88FB-C5168446704AQ44389263-42CF5617-7EDC-4748-8993-87C4AC9BEDDCQ44572397-8162606B-9476-4F6F-B766-C2E50D26C637Q44604949-787942ED-0AD1-456A-BF21-39276E58B36EQ45159173-17AC0873-935E-4339-B02B-9719BDE52D5FQ46340561-DACB0F18-07BE-4459-A687-B7544926310DQ46380767-BD29C063-70C8-4943-9814-3DACAC59CAF4Q47239710-B9485639-EDBB-4809-85CB-48AFE903EF0AQ48042900-236448FF-4E77-45AC-8610-F08ADFDB3EF2Q48641272-E9A2A2C6-C404-4386-9009-3489BB4F1797Q51158260-478A46A0-83D8-4BF2-8135-4FC17D436C20Q52045467-C24EDA24-11E4-4243-B5CB-9C66D0DEF1A0Q52604156-BD080230-EF5E-4EB4-B283-069EE23E2970Q52710300-DCE63D76-6490-4B05-81F5-B131D3A3A4F7Q53728984-03C8814A-4600-44E5-BC8A-6754BE7B0C6DQ53811572-9C39C6B9-299C-401C-BC6F-34AF09CE7B39Q53814517-C599C146-AFA9-4ADE-9169-4D8FBB8C5ADFQ54039847-C7B8567B-2D68-47F4-B360-E23FA6198550Q55043553-4391AF62-91B4-4F05-864B-CB4211B49BF0Q57759790-30AFCCFE-E2AF-488D-AE79-851B0BF5B683
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ana I. Alvarez
@ast
Ana I. Alvarez
@en
Ana I. Alvarez
@es
Ana I. Alvarez
@nl
type
label
Ana I. Alvarez
@ast
Ana I. Alvarez
@en
Ana I. Alvarez
@es
Ana I. Alvarez
@nl
prefLabel
Ana I. Alvarez
@ast
Ana I. Alvarez
@en
Ana I. Alvarez
@es
Ana I. Alvarez
@nl
P1053
H-5669-2015
P106
P1153
7202214777
P21
P31
P3829
P496
0000-0001-9206-9539